BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11362970)

  • 1. New technologies for quantifying HIV: amplification assays directly measure the virus at all stages of infection.
    J Int Assoc Physicians AIDS Care; 1995 Nov; 1(10):14-5. PubMed ID: 11362970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
    Cao Y; Ho DD; Todd J; Kokka R; Urdea M; Lifson JD; Piatak M; Chen S; Hahn BH; Saag MS
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):353-61. PubMed ID: 7786581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Coste J; Montes B; Reynes J; Peeters M; Segarra C; Vendrell JP; Delaporte E; Segondy M
    J Med Virol; 1996 Dec; 50(4):293-302. PubMed ID: 8950685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral load testing.
    Sax P; Flory J
    AIDS Clin Care; 1996 Apr; 8(4):31-2. PubMed ID: 11363258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological and virological markers in HIV infection.
    Vella S
    AIDS Clin Care; 1995 May; 7(5):37-40. PubMed ID: 11362683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
    Piatak M; Saag MS; Yang LC; Clark SJ; Kappes JC; Luk KC; Hahn BH; Shaw GM; Lifson JD
    AIDS; 1993 Nov; 7 Suppl 2():S65-71. PubMed ID: 7909227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia, and unintegrated DNA as viral load markers in pediatric patients.
    Bush CE; Donovan RM; Manzor O; Baxa D; Moore E; Cohen F; Saravolatz LD
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):11-5. PubMed ID: 8825613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of three different commercial procedures for quantifying human immunodeficiency virus type-1 RNA levels.
    Aschbacher R; Monari P; Lolli S; Donzelli C; Colangeli V; Vignoli M; Ramazzotti E; Furlini G; Re MC
    New Microbiol; 1999 Jan; 22(1):1-9. PubMed ID: 10190111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of technics for the diagnosis of the human immunodeficiency virus in infants under 15 months by: viral cultivation, the polymerase chain reaction and antigen p24].
    Muñoz Fernández MA; Obregón González E; Navarro Caspistegui J; Gurbindo Gutiérrez MD; Hernández Sampelayo T; Fernández-Cruz E
    An Esp Pediatr; 1996 Jun; 44(6):540-4. PubMed ID: 8849094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.
    Stevens G; Rekhviashvili N; Scott LE; Gonin R; Stevens W
    J Clin Microbiol; 2005 Feb; 43(2):857-61. PubMed ID: 15695692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the virus.
    Treat Rev; 1995 May; (no 18):5. PubMed ID: 11362593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing HIV. Part 4: Primary therapy. 4.3 The laboratory in managing HIV infection.
    Dwyer DE; Adelstein S; Cunningham AL; Merigan TC
    Med J Aust; 1996 Mar; 164(5):301-3. PubMed ID: 8628167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA].
    Gariglio R; Taborda MA; Bortolozzi R; McDermott JL; Martini I; Borgognone M; Villanova GV; Varnier OE; Giri AA
    Medicina (B Aires); 2004; 64(5):419-28. PubMed ID: 15560543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Virological diagnosis of HIV infection in children].
    Muñoz Fernández MA
    Allergol Immunopathol (Madr); 1998; 26(3):122-9. PubMed ID: 9675394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An approach to antiretroviral treatment of HIV disease. Individualized therapy: the role of viral-burden measures.
    Thompson MA
    Hosp Pract (1995); 1995 Aug; 30 Suppl 1():41-50. PubMed ID: 7635916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of immunocomplex-dissociated serum HIV-1 p24 antigenemia and plasma HIV-1 viral load: assessment of 3,129 paired assays.
    Manfredi R; Borderi M; Re MC; Furlini G; Monari P; Spinosa Guzmán SM; Tadolini M; Talò S; Donzelli C; Maldini C; Chiodo F
    New Microbiol; 1999 Jul; 22(3):269-75. PubMed ID: 10423746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement.
    Ledergerber B; Flepp M; Böni J; Tomasik Z; Cone RW; Lüthy R; Schüpbach J
    J Infect Dis; 2000 Apr; 181(4):1280-8. PubMed ID: 10751136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.